Hyperuricémie et maladie rénale : prise en charge [Management of hyperuricemia in chronic kidney disease]
Fiche du document
2 mars 2022
- doi: 10.53738/REVMED.2022.18.771.379
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2022.18.771.379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/35235261
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_2FCE48D8B05C8
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Sujets proches
Therapy Renal failure, Chronic End-stage kidney disease End-stage renal disease Kidney failure, Chronic ESRD (Disease) Renal insufficiency Renal insufficiency, Chronic Chronic renal insufficiency Chronic kidney failure Podagra illnessCiter ce document
N. Schwotzer et al., « Hyperuricémie et maladie rénale : prise en charge [Management of hyperuricemia in chronic kidney disease] », Serveur académique Lausannois, ID : 10.53738/REVMED.2022.18.771.379
Métriques
Partage / Export
Résumé
Hyperuricemia is often encountered as glomerular filtration rate decreased. It is associated with a more rapid decline of the renal function, but causality has not been demonstrated. Recent studies showed that treatment of hyperuricemia did not affect the progression in chronic kidney disease (CKD) patients. Thus, treatment with hypouricemic drugs of patients suffering of CKD and displaying asymptomatic hyperuricemia is not recommended. However, patients with CKD present often with acute flairs of gout, which might be difficult to treat. Therapeutic options are discussed in this article.